ABBV vs BDX
By Alex · Tickerpine
AbbVie Inc. vs Becton, Dickinson and Company, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | ABBV | BDX |
|---|---|---|
| Price | $295.03 | $218.03 |
| Market cap | $521.50B | $59.39B |
| P/E ratio | 50.7 | 43.1 |
| ROE | — | 5.66% |
| Profit margin | 15.67% | 5.88% |
| Revenue growth | 10.30% | -10.50% |
| Dividend yield | 2.35% | 1.94% |
| Beta | 0.19 | 0.28 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
ABBV vs BDX in plain English
- ABBV is the bigger company — about 8.8× the market cap of BDX.
- BDX is cheaper on earnings (P/E 43.1 vs 50.7).
- ABBV is growing revenue faster (10% vs -10%).
- ABBV has the higher dividend yield (2.35% vs 1.94%).
How would $1,000 have done in each?
ABBV return calculator
See what $1,000 in AbbVie Inc. would be worth today.
BDX return calculator
See what $1,000 in Becton, Dickinson and Company would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.